
TY  - JOUR
TI  - Health Psychology
JO  - International Journal of Psychology
JA  - Int J Psychol
VL  - 51
IS  - S1
SN  - 0020-7594
UR  - https://doi.org/10.1002/ijop.12325
DO  - doi:10.1002/ijop.12325
SP  - 658
EP  - 712
PY  - 2016
ER  - 

TY  - JOUR
AU  - Smith, Lee
AU  - Yang, Lin
AU  - Hamer, Mark
TI  - Handgrip strength, inflammatory markers, and mortality
JO  - Scandinavian Journal of Medicine & Science in Sports
JA  - Scand J Med Sci Sports
VL  - 29
IS  - 8
SN  - 0905-7188
UR  - https://doi.org/10.1111/sms.13433
DO  - doi:10.1111/sms.13433
SP  - 1190
EP  - 1196
KW  - ELSA
KW  - handgrip strength
KW  - inflammatory markers
KW  - mortality
PY  - 2019
AB  - Purpose To investigate the extent to which inflammatory markers explain the association between handgrip strength and mortality. Methods Analyses of data from The English Longitudinal Study of Ageing. Handgrip strength and inflammatory marker data (C-reactive protein and fibrinogen) were collected at baseline (2004/5) and inflammatory marker data at follow-up (2012/13). Participant data were linked with death records. General linear models were used to explore associations between handgrip strength and inflammatory markers at follow-up. Cox proportional hazards regression models were used to examine associations between grip strength and risk of death. Models were estimated with the covariates age, sex, wealth, physical activity, smoking, depressive symptoms, long-standing illness, and adiposity. Results The sample comprised of 5,240 participants (mean age 65.9 (SD 9.4) years; 53.8% female). Over an average 9.7 ± 1.4 years follow-up, there were 650 deaths. Inverse associations were evident between handgrip strength and change in inflammatory markers in women only. There was an association between grip strength and lower risk of mortality in women (hazard ratio = 0.85; 95% CI, 0.74, 0.98) after adjusting for age and wealth. The association was attenuated after adjustment for clinical and behavioral risk factors (0.92; 0.79, 1.07), and further attenuated after adjusting for inflammatory markers (0.95; 0.82, 1.11). Conclusion Higher grip strength is associated with lower levels of inflammation at 8-year follow-up, and inflammatory markers partly explained the association between handgrip strength and mortality.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Brain Pathology
VL  - 20
IS  - s1
SN  - 1015-6305
UR  - https://doi.org/10.1111/j.1750-3639.2010.00420.x
DO  - doi:10.1111/j.1750-3639.2010.00420.x
SP  - 1
EP  - 99
PY  - 2010
ER  - 

TY  - JOUR
TI  - 44th Congress of the International Society of Paediatric Oncology (SIOP) 2012, London, United Kingdom, 5th–8th October, 2012 SIOP abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr. Blood Cancer
VL  - 59
IS  - 6
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.24295
DO  - doi:10.1002/pbc.24295
SP  - 965
EP  - 1152
PY  - 2012
ER  - 

TY  - JOUR
TI  - Poster Discussion
JO  - Journal of Clinical Periodontology
JA  - J Clin Periodontol
VL  - 42
IS  - S17
SN  - 0303-6979
UR  - https://doi.org/10.1111/jcpe.12398
DO  - doi:10.1111/jcpe.12398
SP  - 31
EP  - 63
PY  - 2015
ER  - 

TY  - JOUR
TI  - Focused Conferences
JO  - Basic & Clinical Pharmacology & Toxicology
VL  - 107
IS  - s1
SN  - 1742-7835
UR  - https://doi.org/10.1111/j.1742-7843.2010.00598_2.x
DO  - doi:10.1111/j.1742-7843.2010.00598_2.x
SP  - 7
EP  - 70
PY  - 2010
ER  - 

TY  - JOUR
TI  - 2018 AANEM Annual Meeting Abstract Guide Washington, DC, October 10–13, 2018
JO  - Muscle & Nerve
JA  - Muscle Nerve
VL  - 58
IS  - S2
SN  - 0148-639X
UR  - https://doi.org/10.1002/mus.26353
DO  - doi:10.1002/mus.26353
SP  - S1
EP  - S120
PY  - 2018
ER  - 

TY  - JOUR
TI  - Monday, December 7, 2009 Poster Session 3 8:00 a.m.-6:00 p.m.
JO  - Epilepsia
VL  - 50
IS  - s11
SN  - 0013-9580
UR  - https://doi.org/10.1111/j.1528-1167.2009.02377_10.x
DO  - doi:10.1111/j.1528-1167.2009.02377_10.x
SP  - 328
EP  - 482
PY  - 2009
ER  - 

TY  - JOUR
AU  - Minniti, Caterina P.
AU  - Kato, Gregory J.
TI  - Critical Reviews: How we treat sickle cell patients with leg ulcers
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 91
IS  - 1
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.24134
DO  - doi:10.1002/ajh.24134
SP  - 22
EP  - 30
PY  - 2016
AB  - The past five decades have seen an improvement in the mortality and morbidity of sickle cell disease (SCD) because of prophylaxis against infectious complications, improved and expanded red cell transfusions, implementation of hydroxyurea therapy, and advances in supportive care. Now that the majority of patients in the western hemisphere reaches adulthood, end organ diseases are frequent, which include vasculopathic complications such as chronic leg ulcers. The management of patients with leg ulcers requires the hematologist to lead a team of health care professionals, and investigates the presence of associated, but potentially still occult signs of vasculopathy, such as pulmonary hypertension, renal disease, priapism and retinopathy. These complications may be asynchronous, and long term careful screening is indicated, in order to ensure early diagnosis and intervention. It is crucial to address both the immediate consequences of pain, infection and disability, and long term effects on quality of life, employment and stigma associated with chronic ulceration. Recent insights into their pathophysiology may have practical implications. We propose a holistic approach to the management of patients' physical and emotional problems and mechanisms of ulcers formation and delayed healing. An overview of topical and systemic therapies for chronic ulcers is given, with the understanding that wound care therapy is best left to the wound specialists, medical and surgical, with whom the hematologist must keep an open line of communication. In the absence of evidence-based guidelines, our opinion is based on both a critical review of the literature and our personal clinical and research experience. Am. J. Hematol. 00:000?000, 2015. ? 2015 Wiley Periodicals, Inc. Am. J. Hematol. 91:22?30, 2016. ? 2015 Wiley Periodicals, Inc.
ER  - 

TY  - JOUR
TI  - RSA 2017 Program
JO  - Alcoholism: Clinical and Experimental Research
JA  - Alcohol Clin Exp Res
VL  - 41
IS  - S1
SN  - 0145-6008
UR  - https://doi.org/10.1111/acer.13389
DO  - doi:10.1111/acer.13389
SP  - 5A
EP  - 15A
PY  - 2017
ER  - 

TY  - JOUR
AU  - Goette, Andreas
AU  - Kalman, Jonathan M.
AU  - Aguinaga, Luis
AU  - Akar, Joseph
AU  - Cabrera, Jose Angel
AU  - Chen, Shih Ann
AU  - Chugh, Sumeet S.
AU  - Corradi, Domenico
AU  - D'Avila, Andre
AU  - Dobrev, Dobromir
AU  - Fenelon, Guilherme
AU  - Gonzalez, Mario
AU  - Hatem, Stephane N.
AU  - Helm, Robert
AU  - Hindricks, Gerhard
AU  - Ho, Siew Yen
AU  - Hoit, Brian
AU  - Jalife, Jose
AU  - Kim, Young-Hoon
AU  - Lip, Gregory Y.H.
AU  - Ma, Chang-Sheng
AU  - Marcus, Gregory M.
AU  - Murray, Katherine
AU  - Nogami, Akihiko
AU  - Sanders, Prashanthan
AU  - Uribe, William
AU  - Van Wagoner, David R.
AU  - Nattel, Stanley
AU  - Document Reviewers: Osmar A. Centurion (Paraguay), Karl-Heinz Kuck (Germany), Kristen K. Patton (USA), John L. Sapp (Canada), Martin Stiles (New Zealand), Jesper Hastrup Svendsen (Denmark), and Gaurav A. Upadhyay (USA)
AU  - Review coordinator: Alena Shantsila (UK)
TI  - EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication
JO  - Journal of Arrhythmia
JA  - Journal of Arrhythmia
VL  - 32
IS  - 4
SN  - 1880-4276
UR  - https://doi.org/10.1016/j.joa.2016.05.002
DO  - doi:10.1016/j.joa.2016.05.002
SP  - 247
EP  - 278
PY  - 2016
ER  - 

TY  - JOUR
TI  - Short Communications
JO  - European Journal of Neurology
VL  - 17
IS  - s3
SN  - 1351-5101
UR  - https://doi.org/10.1111/j.1468-1331.2010.03231.x
DO  - doi:10.1111/j.1468-1331.2010.03231.x
SP  - 20
EP  - 71
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts from the Bisphosphonates 50th anniversary meeting, July 15–17, 2019
JO  - JBMR Plus
JA  - JBMR Plus
VL  - 3
IS  - S3
SN  - 2475-0328
UR  - https://doi.org/10.1002/jbm4.10229
DO  - doi:10.1002/jbm4.10229
SP  - S1
EP  - S84
PY  - 2019
ER  - 

TY  - JOUR
TI  - Vascular Surgery Program Abstracts
JO  - ANZ Journal of Surgery
JA  - ANZ J Surg
VL  - 84
IS  - S1
SN  - 1445-1433
UR  - https://doi.org/10.1111/ans.12633
DO  - doi:10.1111/ans.12633
SP  - 213
EP  - 222
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Session 2, Monday 12 September
JO  - European Journal of Neurology
VL  - 18
IS  - s2
SN  - 1351-5101
UR  - https://doi.org/10.1111/j.1468-1331.2011.03552.x
DO  - doi:10.1111/j.1468-1331.2011.03552.x
SP  - 344
EP  - 620
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - HPB
JA  - HPB
VL  - 17
IS  - S2
SN  - 1365-182X
UR  - https://doi.org/10.1111/hpb.12403
DO  - doi:10.1111/hpb.12403
SP  - 25
EP  - 266
PY  - 2015
ER  - 

TY  - JOUR
TI  - E-Poster Exhibition | APDW 2019
JO  - Journal of Gastroenterology and Hepatology
JA  - Journal of Gastroenterology and Hepatology
VL  - 34
IS  - S3
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.14865
DO  - doi:10.1111/jgh.14865
SP  - 583
EP  - 853
PY  - 2019
ER  - 

TY  - JOUR
AU  - Tang, Sydney Chi-Wai
AU  - Wong, Andrew Kui-Man
AU  - Mak, Siu-Ka
TI  - Clinical practice guidelines for the provision of renal service in Hong Kong: General Nephrology
JO  - Nephrology
JA  - Nephrology
VL  - 24
IS  - S1
SN  - 1320-5358
UR  - https://doi.org/10.1111/nep.13500
DO  - doi:10.1111/nep.13500
SP  - 9
EP  - 26
PY  - 2019
ER  - 

TY  - JOUR
AU  - Berney, Thierry
AU  - Boffa, Catherine
AU  - Augustine, Titus
AU  - Badet, Lionel
AU  - de Koning, Eelco
AU  - Pratschke, Johann
AU  - Socci, Carlo
AU  - Friend, Peter
TI  - Utilization of organs from donors after circulatory death for vascularized pancreas and islet of Langerhans transplantation: recommendations from an expert group
JO  - Transplant International
JA  - Transpl Int
VL  - 29
IS  - 7
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.12681
DO  - doi:10.1111/tri.12681
SP  - 798
EP  - 806
KW  - donation after cardiac death
KW  - donation after circulatory death
KW  - guidelines
KW  - islet of Langerhans
KW  - non-heart beating donation
KW  - pancreas
KW  - review
PY  - 2016
AB  - Summary Donation after circulatory death (DCD) donors are increasingly being used as a source of pancreas allografts for vascularized organ and islet transplantation. We provide practice guidelines aiming to increase DCD pancreas utilization. We review risk assessment and donor selection criteria. We report suggested factors in donor and recipient clinical management and provide an overview of the activities and outcomes of vascularized pancreas and islet transplantation.
ER  - 

AU  - Rutter, Michael
AU  - Pine, Daniel S.
C7  - pp. 17-30
TI  - Diagnosis, diagnostic formulations, and classification
SN  - 9781118381960
UR  - https://doi.org/10.1002/9781118381953.ch2
DO  - doi:10.1002/9781118381953.ch2
SP  - 17-30
KW  - Neural ‘signatures’
KW  - dimensions vs categories
KW  - validity
KW  - DSM-5
KW  - ICD-11
KW  - lumping vs splitting
KW  - threshold for diagnosis
PY  - 2016
AB  - Summary The differences among diagnosis, diagnostic formulations and classification, and between clinical and research classifications, are discussed. The current impossibility of basing classification on brain circuitry is noted. It is argued that both dimensional and categorical approaches are useful, and should be combined because they provide different information. The validation of diagnostic categories is reviewed in relation to age trends and sex differences; familiality and genetics; psychosocial correlates; long-term course; drug response; cognitive impairments; and biological findings. A 3-level organisational structure is supported.
ER  - 
